GNH USA

Europe — EMA

Methotrexate Afortas

GNH USA supplies Methotrexate Afortas (Methotrexate), a folate antagonist for rheumatoid arthritis, psoriasis and certain cancers.

Methotrexate

Request sourcing

1
Pack/s

What is Methotrexate?

Methotrexate, the active ingredient in Methotrexate Afortas, is a folate antagonist presented as an oral tablet for oral use. It is employed to treat rheumatoid arthritis, psoriasis, certain leukemias and lymphomas, and gestational trophoblastic disease.

GNH USA supplies Methotrexate Afortas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

What is Methotrexate used for?

Methotrexate acts on diseases that involve abnormal cell proliferation or immune dysregulation. - Rheumatoid arthritis: reduces joint inflammation and slows disease progression. - Psoriasis: decreases skin cell turnover and plaque formation. - Acute lymphoblastic leukemia: impairs malignant lymphoblast replication. - Non‑Hodgkin lymphoma: inhibits growth of lymphoma cells. - Gestational trophoblastic disease: promotes resolution of abnormal trophoblastic tissue.

What are the side effects of Methotrexate?

Methotrexate may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea or vomiting. - Fatigue or malaise. - Oral mucosal ulceration. - Mild liver enzyme elevation. - Decreased white blood cell count. - Diarrhea.

Serious or Rare Side Effects: - Severe hepatic toxicity or fibrosis. - Pulmonary fibrosis or interstitial pneumonitis. - Life‑threatening bone marrow suppression. - Acute renal failure. - Severe cutaneous reactions such as Stevens‑Johnson syndrome. - Neurotoxicity presenting as seizures or encephalopathy.

What precautions apply to Methotrexate?

Methotrexate requires careful monitoring and specific safety measures. - Pregnancy: contraindicated; teratogenic risk is category X. - Renal function: assess creatinine clearance before initiation and periodically thereafter. - Hepatic function: monitor liver enzymes regularly; avoid in pre‑existing severe liver disease. - Hematology: perform complete blood counts to detect marrow suppression. - Drug interactions: avoid concurrent high‑dose NSAIDs and live vaccines. - Store below 25°C: keep in the original pack, protect from moisture.

What does Methotrexate interact with?

Methotrexate interacts with several medicines that can alter its efficacy or toxicity.

Major Interactions (Avoid): - High‑dose NSAIDs: increase risk of renal toxicity and gastrointestinal ulceration. - Live vaccines: may precipitate severe infection due to immunosuppression. - Trimethoprim‑sulfamethoxazole: can enhance myelosuppression.

Moderate Interactions (Monitor Closely): - Azathioprine: additive bone‑marrow suppression. - Proton‑pump inhibitors: may increase methotrexate plasma levels. - Sulfasalazine: potential for enhanced hepatotoxicity. - Penicillins: may reduce renal clearance of methotrexate.

Frequently asked questions

What conditions is Methotrexate Afortas used for?+
Methotrexate Afortas is indicated for rheumatoid arthritis, moderate to severe plaque psoriasis, acute lymphoblastic leukemia, non‑Hodgkin lymphoma, and gestational trophoblastic disease. In each case the drug works by inhibiting cell proliferation or modulating the immune response, helping to control disease activity.
How does methotrexate work in the body?+
Methotrexate blocks the enzyme dihydrofolate reductase, which is essential for converting folate into its active form. This interruption reduces the synthesis of DNA, RNA, and proteins, particularly affecting rapidly dividing cells such as immune cells and cancer cells, thereby providing immunosuppressive and antineoplastic effects.
What is the usual dose of Methotrexate Afortas?+
The specific dose of Methotrexate Afortas is determined by the prescribing clinician based on the patient’s condition, disease severity, renal and hepatic function, and other individual factors. Only a qualified healthcare professional should set the dosing regimen.
Is Methotrexate Afortas safe during pregnancy or breastfeeding?+
Methotrexate is classified as pregnancy category X because it is known to cause fetal malformations and embryotoxicity. It is contraindicated in pregnancy and should be discontinued well before conception. Breastfeeding is also not recommended, as methotrexate can be excreted in milk and affect the infant.
How do I order Methotrexate Afortas from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.
How does Methotrexate Afortas compare with other folate antagonists?+
Methotrexate is the most widely used folate antagonist and offers a broad therapeutic range across rheumatology and oncology. Compared with newer agents such as leflunomide or biologics, methotrexate is generally less expensive but may require more intensive monitoring for hepatic, renal, and hematologic toxicity.
What are the recommended storage conditions for Methotrexate Afortas?+
Methotrexate Afortas should be stored at temperatures below 25 °C, in its original packaging, and protected from moisture and direct sunlight. Keeping the product in a dry, cool environment helps maintain its stability and potency throughout its shelf life.
How is Methotrexate Afortas administered?+
Methotrexate Afortas is supplied as an oral tablet and is taken by mouth with water. The prescribing physician will advise whether it should be taken with food or on an empty stomach, and the exact dosing schedule, which may be weekly or as otherwise directed.
What are the most serious risks associated with Methotrexate Afortas?+
The most serious risks include severe liver toxicity, pulmonary fibrosis, life‑threatening bone‑marrow suppression, and renal failure. Patients should be monitored regularly for signs of organ dysfunction, and any symptoms such as persistent cough, jaundice, unexplained bruising, or decreased urine output should prompt immediate medical evaluation.
Who should not use Methotrexate Afortas?+
Methotrexate Afortas is contraindicated in pregnant women, individuals with severe hepatic or renal impairment, patients with known hypersensitivity to methotrexate, and those receiving live vaccines. Caution is also advised for patients with pre‑existing blood dyscrasias or uncontrolled infections.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Methotrexate
Route
Oral Use
Manufacturer
2care4 Generics Aps
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU